All Stories

  1. Beyond Clinical Features: Multidimensional Insights into Eating Behavior Disturbances in Frontotemporal Lobar Degeneration and Alzheimer’s Disease
  2. Varicella zoster virus meningoencephalitis and vasculopathy in an immunocompromised patient with rheumatoid arthritis: a diagnostic challenge
  3. Need for combined therapy for a rare case of autoimmune autonomic ganglionopathy: A case report
  4. Classifying and Monitoring Primary Progressive Aphasia in the Greek Population: A “Mini Linguistic State Examination (MLSE)” Tool
  5. The Evolving Role of FDG–PET in Behavioral Variant Frontotemporal Dementia: Current Applications and Future Opportunities
  6. Creutzfeldt–Jakob Disease Mimicking Brain Sagging Dementia: A Rare Manifestation in a 53-Year-Old Woman
  7. Functional Impairment in Behavioral Variant Frontotemporal Dementia: Cognitive, Behavioral, Personality, and Brain Perfusion Contributions
  8. Bridging Epilepsy and Cognitive Impairment: Insights from EEG and Clinical Observations in a Retrospective Case Series
  9. Functional Impairment in Behavioral Variant Frontotemporal Dementia: Cognitive, Behavioral, Personality, and Brain Perfusion Contributions
  10. The predictive value of social cognition assessment for 1-year follow-up functional outcomes in behavioral variant frontotemporal dementia
  11. A Complementary Dataset of Scalp EEG Recordings Featuring Participants with Alzheimer’s Disease, Frontotemporal Dementia, and Healthy Controls, Obtained from Photostimulation EEG
  12. Teaching NeuroImage: The House Sign in Behavioral Variant Frontotemporal Dementia
  13. Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer’s Disease, Creutzfeldt–Jakob Disease and Cerebral Amyloid Angiopathy
  14. Regional cerebral blood flow in behavioral variant of FTD: hypoperfusion patterns and clinical associations
  15. The Role of a Computerized Cognitive Intervention Program on the Neuropsychiatric Symptoms in Mild Cognitive Impairment
  16. Tumefactive cerebral amyloid angiopathy – related inflammation
  17. Alzheimer’s Disease and Epilepsy: Exploring Shared Pathways and Promising Biomarkers for Future Treatments
  18. Production of Complex Sentences in the Semantic Variant of Primary Progressive Aphasia: Neuropsychological, Clinical, Neuroanatomical and Demographic Correlates
  19. Cerebellar syndrome: do not miss anti-Tr antibodies testing
  20. Optical Coherence Tomography as a Biomarker in the Differential Diagnosis between Parkinson’s Disease and Atypical Parkinsonian Syndromes: A Narrative Review
  21. Apraxia Patterns for the Differentiation between Alzheimer’s Disease and Frontotemporal Dementia Variants
  22. Screening for Executive Impairment in Patients with Frontotemporal Dementia: Evidence from the Greek Version of the Frontier Executive Screen
  23. Correlates of Functional Impairment in Patients with the Behavioral Variant of Frontotemporal Dementia: A PRISMA-Compliant Systematic Review
  24. Detection and Prevention of Mild Cognitive Impairment and Dementia
  25. Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
  26. A Dataset of Scalp EEG Recordings of Alzheimer’s Disease, Frontotemporal Dementia and Healthy Subjects from Routine EEG
  27. The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
  28. EEG-Neurofeedback as a Potential Therapeutic Approach for Cognitive Deficits in Patients with Dementia, Multiple Sclerosis, Stroke and Traumatic Brain Injury
  29. Emergence of artistic talent in logopenic variant of primary progressive aphasia: a case report
  30. Assess of Combinations of Non-Pharmacological Interventions for the Reduction of Irritability in Patients with Dementia and their Caregivers: A Cross-Over RCT
  31. EEG – Imaging Evolution of the MV2 Subtype of Sporadic Creutzfeldt-Jakob Disease During the two-Year Course of the Disease
  32. Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults
  33. Differentiating Degenerative from Vascular Dementia with the Help of Optical Coherence Tomography Angiography Biomarkers
  34. Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium
  35. Genetic causes of acute encephalopathy in adults: beyond inherited metabolic and epileptic disorders
  36. Non-Pharmacological Interventions for Wandering/Aberrant Motor Behaviour in Patients with Dementia
  37. Preliminary validation of the apraxia battery for adults-second edition (ABA-2) in Greek patients with dementia
  38. Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
  39. Alzheimer’s Disease and Frontotemporal Dementia: A Robust Classification Method of EEG Signals and a Comparison of Validation Methods
  40. Hereditary diffuse leukoencephalopathy with spheroids mimicking primary progressive aphasia: report of a Greek case
  41. Inhibitory control is associated with medication adherence in young HIV patients without comorbidities
  42. Primary progression in NMOSD. Does it really exist?
  43. Selective executive impairments as neuroimmumological manifestations of the human immunodeficiency virus
  44. Hyper-religiosity in frontotemporal dementia with predominant atrophy of the right temporal lobe
  45. Biomarkers in Rare Demyelinating Disease of the Central Nervous System
  46. Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis
  47. Acute Pain in the Neck: Don’t Miss the Crown!
  48. Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk
  49. Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study
  50. Time reference, morphology and prototypicality: tense production in stroke aphasia and semantic dementia in Greek
  51. Systemic lupus erythematosus in a patient with multiple system atrophy
  52. Analysis of electroencephalographic signals complexity regarding Alzheimer's Disease
  53. EEG Window Length Evaluation for the Detection of Alzheimer’s Disease over Different Brain Regions
  54. Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study
  55. Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
  56. Acute Finger Paralysis: A Case Report of Cortical Ischemic Stroke
  57. Compound production in agrammatism: Evidence from stroke-induced and Primary Progressive Aphasia
  58. The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians
  59. Sentence Production in Semantic Dementia
  60. A massive ganglion cell tumor with unusual localization and favorable outcome
  61. Cognitive Reserve Hypothesis in Frontotemporal Dementia: Evidence from a Brain SPECT Study in a Series of Greek Frontotemporal Dementia Patients
  62. Charcot-Marie-Tooth Disease 1X Simulating Paraparetic Guillain-Barre Syndrome
  63. Corticosteroids in neurological disorders: The dark side
  64. Neuromyotonia Confined to Faciobulbar Muscles in a Patient with Myasthenia Gravis
  65. Cerebral cavernomatosis
  66. Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients
  67. The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
  68. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis
  69. Paroxysmal hemidystonia in the setting of multiple sclerosis
  70. Isolated IgG4-related hypertrophic pachymeningitis
  71. Adaptation of the Cognitive Reserve Index Questionnaire (CRIq) for the Greek population
  72. Muscular dystrophy in a patient with multiple sclerosis. Another “double-trouble”?
  73. Anti-NMDA receptor encephalitis possibly triggered by measles virus
  74. Expanding schwannomatosis phenotype
  75. Drawing perseveration in the behavioral variant of frontotemporal dementia
  76. Spinal cord involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and MRI study
  77. Intrathecal Gadolinium for Magnetic Resonance Myelography in Spontaneous Intracranial Hypotension: Valuable But May Be Risky
  78. Levetiracetam as alternative treatment in Jeavons syndrome
  79. Early onset degenerative dementias: demographic characteristics and etiologic classification in a tertiary referral center
  80. Internal Carotid Artery Floating Thrombus in Relapsing Polychondritis
  81. Neurosyphilis Presenting as Primary Progressive Aphasia
  82. Primary Antiphospholipid Syndrome Mimicking Demyelinating Disorders
  83. Acute Confusion After Minimal Hepatic Encephalopathy
  84. Coexistence of Multiple Sclerosis and Ankylosing Spondylitis: Report of Two Cases
  85. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory
  86. Sequential peripheral neuropathy and myelopathy in a neurosarcoidosis patient
  87. Verb Production in Stroke Induced Aphasia and Semantic Dementia: Similarities and Dissociations
  88. Looking for the Boundaries of Lexical Representations in Semantic Dementia: Evidence from Pseudowords in Greek
  89. Mild cognitive impairment: effect of education on the verbal and nonverbal tasks performance decline
  90. A 60-year-old woman with rapidly progressive memory loss
  91. The frontotemporal dementias in a tertiary referral center: Classification and demographic characteristics in a series of 232 cases
  92. The Gilliatt-Sumner hand
  93. Brainstem Encephalitis with a Favorable Outcome
  94. Acute Pisa Syndrome After Administration of a Single Dose of Donepezil
  95. Aortic Graft Infection as a Cause of Multiple Brain Infarcts
  96. How Safe Could Intrathecal Transplantation of Mesenchymal Stem Cells Be Considered in Multiple Sclerosis?
  97. Cervical epidural plasmacytoma presenting as ascending paraparesis
  98. Confusional State in the Syndrome of HaNDL
  99. Adaptation of Addenbrooke’s Cognitive Examination-Revised for the Greek population
  100. Rich Collaterals in Clinically Unsuspected Basilar Artery Occlusion—As Good as It Gets
  101. Transient epileptic amnesia in a memory clinic setting: A report of three cases
  102. Autoimmune autonomic ganglionopathy after a CNS infection
  103. How Reversible are ‘˜Reversible Dementias’?
  104. Salt-free diet and pregnancy-related central pontine myelinolysis: “To diet or not?”
  105. Verb Retrieval and Inflection in Fluent Aphasia and Semantic Dementia: Insights from Different Verb Classes in Greek
  106. Parry-Romberg Syndrome Associated with Localized Scleroderma
  107. Acute paraplegia in painless aortic dissection. Rich imaging with poor outcome
  108. Neuroimaging in human prion disease: Searching in the mist
  109. Studying Social Cognition in Patients with Schizophrenia and Patients with Frontotemporal Dementia: Theory of Mind and the Perception of Sarcasm
  110. Can ‘Football-Team Color-Code’ Compensate for Anomia? The case study of FN, a patient with color anomia
  111. The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia
  112. Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient
  113. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH